Patent Law

CureVac Expands Its mRNA Patent Lawsuit Over Pfizer

CureVac NV punched back against Pfizer Inc. and its German partner BioNTech recently by expanding its three claims of patent infringement to nine claims over the mRNA technology used in the companies’ COVID-19 vaccine. CureVac also disclosed that a U.S....
Read More

Supreme Court Ruling Has Ramifications for Genus Claims and Patent Law

After years of ongoing litigation, the Supreme Court ruled on Amgen vs. Sanofi on May 18, 2023. The decision regarding a patent dispute over a cholesterol drug could have ramifications regarding future genus claims and patent law protection for medical...
Read More